Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Lixte Biotechnology Holdings Inc    LIXT

LIXTE BIOTECHNOLOGY HOLDINGS INC

(LIXT)
SummaryQuotesChartsNewsCompany 
Business Summary
Lixte Biotechnology Holdings, Inc., including its subsidiary, Lixte Biotechnology, Inc., is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs compounds to attack those targets. The Company's primary focus is developing new treatments for human cancers. The Company designs drugs for which there are existing data suggesting that they may affect the altered pathways of the cancer cell and may be given safely to humans. This approach has led to the development of over two classes of drugs for the treatment of cancer, consisting of protein phosphatase inhibitors (PTase-i), designated by the Company as the LB-100 series of compounds, and histone deacetylase inhibitors (HDACi), designated by the Company as the LB-200 series of compounds. Compounds of both types also have use in the prevention and treatment of neurodegenerative diseases.

Number of employees : 1 people.
Managers
NameAgeSinceTitle
John S. Kovach, MD822005President, CEO, CFO, Director & CAO
Philip F. Palmedo, PhD852006Independent Director
Stephen J. Forman, MD702016Director
Yun Yen MD, PhD642018Director
Winson Ho, MD-2018Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 67,045,814 21,092,851 31.5% 0 0.0% 31.3%
Stock B 0 350,000 0 0.0% 0 0.0%
Shareholders
NameEquities%
Gil Schwartzberg 9,669,940 16.7%
John S. Kovach, MD 9,114,503 15.7%
John & Barbara Kovach 2015 Trust 8,000,000 13.8%
Arthur Riggs 6,110,000 10.5%
Hung Tak Ho 6,000,000 10.3%
Robert Greenberg 5,650,000 9.73%
Lalit R. Bahl 4,000,000 6.89%
Philip F. Palmedo, PhD 1,166,020 2.01%
Stephen J. Forman, MD 122,500 0.21%
Eric Forman 100,000 0.17%
Company contact information
Lixte Biotechnology Holdings, Inc.
248 Route 25A No. 2
East Setauket, NY 11733

Phone : +1.631.942.7959
Fax : +1.631.982.5050
Web : http://www.lixte.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
LIXTE BIOTECHNOLOGY HOLDINGS INC2.10%0
IQVIA HOLDINGS INC32.77%26 223
LONZA GROUP31.41%24 012
CELLTRION, INC.--.--%20 953
INCYTE CORPORATION33.46%17 061
EXACT SCIENCES CORPORATION83.36%13 037
SEATTLE GENETICS, INC.27.67%10 947
IONIS PHARMACEUTICALS INC20.05%9 108
QIAGEN17.39%8 762
SAGE THERAPEUTICS INC89.82%8 652
ICON PLC14.19%7 577
BIO-TECHNE CORP43.37%7 497
ALNYLAM PHARMACEUTICALS, INC.-1.29%7 124
GALAPAGOS38.16%6 305
GALAPAGOS NV (ADR)37.18%6 298
CHARLES RIVER LABORATORIES INTL. INC17.30%6 016
NEKTAR THERAPEUTICS7.51%5 937
PRA HEALTH SCIENCES INC7.29%5 717
HANGZHOU TIGERMED CONSULTING CO LTD--.--%4 750
SYNEOS HEALTH INC23.79%4 234
BB BIOTECH AG16.87%3 695
Connections : Lixte Biotechnology Holdin
California Institute of Technology
Taipei Medical University
The Chinese Oncology Society
City of Hope Comprehensive Cancer Center
IRG Carbon LLC
Kepler Asset Management LLC
Palmedo Associates